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Abstract
Background: Laser capture microdissection (LCM) has successfully isolated pure cell populations from tissue
sections and the combination of LCM with standard genomic and proteomic methods has revolutionized
molecular analysis of complex tissue. However, the quantity and quality of material recovered after LCM is often
still limited for analysis by using whole genomic and proteomic approaches. To procure high quality and quantity
of RNA after LCM, we optimized the procedures on tissue preparations and applied the approach for cell type-
specific miRNA expression profiling in colorectal tumors.
Results: We found that the ethanol fixation of tissue sections for 2 hours had the maximum improvement of RNA
quality (1.8 fold, p = 0.0014) and quantity (1.5 fold, p = 0.066). Overall, the quality (RNA integrity number, RIN) for
the microdissected colorectal tissues was 5.2 ± 1.5 (average ± SD) for normal (n = 43), 5.7 ± 1.1 for adenomas (n =
14) and 7.2 ± 1.2 for carcinomas (n = 44). We then compared miRNA expression profiles of 18 colorectal tissues (6
normal, 6 adenomas and 6 carcinomas) between LCM selected epithelial cells versus stromal cells using Agilent
miRNA microarrays. We identified 51 differentially expressed miRNAs (p <= 0.001) between these two cell types.
We found that the miRNAs in the epithelial cells could differentiate adenomas from normal and carcinomas.
However, the miRNAs in the stromal and mixed cells could not separate adenomas from normal tissues. Finally, we
applied quantitative RT-PCR to cross-verify the expression patterns of 7 different miRNAs using 8 LCM-selected
epithelial cells and found the excellent correlation of the fold changes between the two platforms (R = 0.996).
Conclusions: Our study demonstrates the feasibility and potential power of discovering cell type-specific miRNA
biomarkers in complex tissue using combination of LCM with genome-wide miRNA analysis.
Background
Molecular profiling of clinical tissue specimens is fre-
quently complicated by their cellular heterogeneity.
Laser capture microdissection (LCM) has successfully
been used to tackle this problem by isolating pure cell
populations from tissue sections [1-3] and the combina-
tion of LCM with standard genomic and proteomic
methods has revolutionized molecular analysis of com-
plex tissue. It has allowed for the discrimination of
genomic changes, differential expressions and subse-
quent signaling effects for a variety of proteins in diag-
nostic tissues [4-10]. Despite these advances, the
quantity and quality of material recovered after LCM is
often still limited for analysis by using whole genomic
and proteomic approaches [2,11].
MicroRNAs (miRNAs) play important regulatory roles
in various cellular pathways including development, cell
proliferation, differentiation and apoptosis [12-14].
Demonstrated abnormal expression patterns of miRNAs
in human disease tissues highlight their potential use as
diagnostic and prognostic biomarkers, especially in the
case of cancer [15-20]. In fact, miRNAs have already
been demonstrated to function as both tumor
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NAs have advantages over mRNAs as cancer biomar-
kers, since they are very stable in vitro [15] and long-
lived in vivo [23]. So far, the large majority of published
miRNA expression studies utilized whole tumor tissues
without separating the truly transformed cancerous cells
from those other cell types commonly present within a
tumor (e.g. immune, stroma cells and new vasculature,
etc). Analysis of such complex tissues could conceal the
specific signature of the particular cell type of interest.
A potentially powerful method to develop diagnostic
tests would be to correlate cell type-specific miRNA
profiles with pathologic and clinical outcomes.
Combination of LCM and whole genome analysis is
an ideal method for cell type-specific expression profil-
ing in complex tissue, however, such a combination has
not been widely applied to discover miRNA biomarkers
in solid tumors. To explore the possibility of using LCM
for genome-wide miRNA analysis, we optimized the
procedures on tissue preparation and then compared
the miRNA expression profiles of 18 colorectal tissues
in LCM selected epithelial cells and stromal cells using
Agilent miRNA microarrays. We then applied quantita-
tive RT-PCR to cross-verify the expression patterns of 7
different miRNAs using 8 LCM-selected epithelial cells.
In this study, we demonstrate a significant improvement
in RNA quality and quantity by prolonged ethanol fixa-
tion of tissue sections. We further present 51 signifi-
cantly differentially expressed miRNAs between the
epithelial and stromal cells from colorectal tissues. We
then show that the miRNAs in the epithelial cells could
differentiate adenomas from normal and carcinomas,
however, the miRNAs in the stromal and mixed cells
could not separate adenomas from normal tissues. We
finally illustrate the correlation of the fold changes
between the microarray and quantitative RT-PCR. To
our knowledge, this work is the first demonstration of
the feasibility and potential power of using a combina-
tion of LCM with genome-wide miRNA analysis on dis-
covering cell type-specific miRNA biomarkers in
complex tissue.
Results
Effect of ethanol fixation on RNA quality and quantity
To assess the effect of ethanol fixation on RNA quality
and quantity, we immediately fixed fresh tissue sec-
tions with 100% ethanol for 10 minutes, and then
stored the slides at -80°C for 2, 5 and 24 hours. The
experimental conditions and their corresponding RIN
scores are shown in Table 1. RNA quality and quantity
of these sections in presence and absence of ethanol
fixation are displayed in Figure 1. Overall, the ethanol
fixation significantly improved RNA quality (1.6 fold
with p = 2.86E-10, Figure 1A) and quantity (1.2 fold
with p = 0.006, Figure 1B). The maximum improve-
ment of the quality (1.81 fold, p = 0.0014) and quantity
(1.52 fold, p = 0.066) were observed in storing the sec-
tions with 100% ethanol at -80°C for 2 hours (Figures
1C and 1D).
Effect of RNase inhibitor on RNA quality and quantity
Besides the fixation, we evaluated the effect of RNase
inhibitor treatment on the tissue preparation. RNA qual-
ity and quantity of the tissue sections in presence and
absence of an RNase inhibitor are shown in Additional
file 1. The presence of the RNase inhibitor reduced both
RNA quality and quantity of one sample (S6), whilst
slightly improved the RNA quantity in two samples (S1
and S5). Essentially, there was no considerable improve-
ment in both quality and quantity of RNA recovered
from the tissue sections with the inhibitor treatment.
Effect of LCM on RNA quality
Using the improved protocol for tissue preparation, we
first determined RNA quality in the hematoxylin-stained
sections with and without LCM. All the samples were
subjected to the same fixation and staining processes
but the only difference was the use of microdissection.
The RIN score was 7.6 ± 0.8 (average ± SD) for the sec-
tions without LCM and 5.8 ± 1.4 (average ± SD) for the
sections with LCM (Figure 2A). Compared to the sec-
tions without LCM, the RIN score was decreased by
30% during the microdissection (p = 0.004). We then
examined the consistency of RNA quality for the LCM
selected epithelial cells derived from 101 colorectal tis-
sues (43 normal, 14 adenomas and 44 carcinomas). On
average, the RIN score was 5.2 ± 1.5 (average ± SD) for
normal, 5.7 ± 1.1 (average ± SD) for adenoma and 7.2 ±
1.2 (average ± SD) for carcinoma tissues (Figure 2B).
Reliability of LCM and miRNA analysis
Replicate experiments were performed to determine the
reliability of combining LCM with genome-wide miRNA
analysis. The epithelial cells were microdissected on 61
individual colorectal tissues including 24 normal, 13
tubular adenomas and 24 Dukes’ C carcinomas. We per-
formed array hybridizations on these epithelial cells and
determined the correlation amongst individual samples
derived from the same tissue type (Figures 3A, 3B and
3C). The average correlation (R) of epithelial cells iso-
lated from normal tissues, tubular adenomas and Dukes’
C carcinomas was 0.942, 0.963 and 0.937, respectively.
To determine the variability of the LCM protocol, we
performed triplicate LCM experiments on the same
tumor tissue and hybridized the LCM-selected epithelial
cells on three individual microarrays. As shown in
Figure 3D, the correlation (R) amongst the triplicate
experiments was 0.999.
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Page 2 of 13Table 1 Experimental conditions for tissue preparations
Experiment Section Ethanol fixation Storage at -80°C Inhibitor* Staining LCM RIN & SD
Ethanol fixation (n = 48)
A-control 6 no no no no no 2.7 ± 0.5
A 6 10 min no no no no 4.8 ± 1.6
B-control 6 no 2 h no no no 3.4 ± 0.8
B 6 10 min 2 h no no no 6.1 ± 1.9
C-control 6 no 5 h no no no 3.1 ± 1.0
C 6 10 min 5 h no no no 4.9 ± 2.1
D-control 6 no 24 h no no no 2.9 ± 0.7
D 6 10 min 24 h no no no 4.4 ± 1.6
Rnase inhibitor (n = 12)
E-control 6 no no no no no 3.4 ± 1.9
E 6 no no 5 min no no 2.8 ± 0.9
LCM (n = 22)
F-control 11 10 min 2 h no 1 min no 7.6 ± 0.8
F 11 10 min 2 h no 1 min yes 5.8 ± 1.4
*Add RNase inhibitor to hemotoxylin solution.
Figure 1 Effect of ethanol fixation on RNA quality and quantity. A) RNA quality (RIN scores) of the tissue sections in the presence (n = 24)
and absence (n = 24) of ethanol fixation; B) RNA quantity (ng) of the tissue sections in the presence (n = 24) and absence (n = 24) of ethanol
fixation; C) RIN scores of the tissue sections over four time points in the presence (n = 6 per time point) and absence (n = 6 per time point) of
ethanol fixation and D) RNA quantity (ng) of the tissue sections over four time points in the presence (n = 6 per time point) and absence (n = 6
per time point) of ethanol fixation. Error bars indicate the corresponding SD. The large errors of the experiments were due to the fact that each
tested group consisted of three different tissue types (normal, adenoma and carcinoma) which had the different RNA quality and quantity.
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Page 3 of 13Cell type-specific miRNA expression profiles
Using Agilent miRNA microarrays containing 723
human miRNA probe sets, we profiled the miRNA
expression of 18 colorectal tissues in LCM selected
epithelial and stromal cells. Significance analysis resulted
in the identification of 51 miRNAs as differentially
expressed between the epithelial and stromal cell types
(Table 2). Figure 4A illustrates an unsupervised
hierarchical clustering of these differentially expressed
miRNAs and shows that the clustering placed 18/18
epithelial cells in one group and 18/18 stromal cells in
another group. Expression levels of 723 human miRNAs
in the epithelial and stromal cells of colorectal tissues
are given in Additional file 2.
We then assessed the miRNA expression profiles of
the colorectal tumors in the epithelial cells and
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Figure 2 Effect of LCM on RNA quality. A) RNA quality (RIN scores) of the hematoxylin-stained sections with (n = 11) and without (n = 11)
LCM and B) RNA quality (RIN scores) of the LCM selected epithelial cells derived from 43 normal, 14 adenoma and 44 carcinoma tissues. Error
bars indicate the corresponding SD.
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Page 4 of 13identified 26 miRNAs that could differentiate adenomas
from normal and carcinoma tissues (Figure 4B, Addi-
tional file 3). We further evaluated the miRNA profiles
of the colorectal tumors in the stromal cells and identi-
fied 21 differentially expressed miRNAs that separated
normal-adenomas into one group and carcinomas into
another group (Figure 4C, Additional file 4). We finally
examined the miRNA profiles of the colorectal tumors
in the mixed cell types (epithelial and stromal cells) and
identified 46 differentially expressed miRNAs amongst
normal, adenoma and carcinoma tissues (Figure 4D,
Additional file 5). The similar cases were observed in
both stromal and mixed cell types where the miRNAs
could not separate adenomas from normal tissues.
We compared the expression profiles of 5 miRNAs in
colorectal tumors with data previously published [24].
Schetter et al. used whole colorectal tissues while our
study used LCM selected epithelial cells. Using the
whole colorectal tissues, significant fold changes were
identified in only one miRNA for adenomas and 5 miR-
NAs for carcinomas, while considerable changes were
seen in 3 miRNAs for adenomas and 4 miRNAs for
carcinomas when we used the pure epithelial cells
(Table 3). The overall fold-changes obtained on the
whole colorectal tissues were considerably lower than
those determined using the pure epithelial cells.
Across-platform comparison
To examine consistency with other platform, data from
quantitative RT-PCR were generated on 7 miRNAs
using 8 LCM-selected epithelial cells derived from 4
pairs of colorectal tumor tissues. The correlation (R) of
fold changes between Agilent miRNA microarrays and
quantitative RT-PCR was 0.996. The expression patterns
of the miRNAs for 4 pairs of the colorectal tumors are
shown in Figure 5. The results demonstrate that the
miRNA signatures discovered using Agilent miRNA
microarrays are highly reliable.
Discussion
Combination of LCM with genome-wide miRNA analy-
sis has not been widely applied to discover miRNA
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Figure 3 Reliability of LCM and miRNA analysis. A) correlation amongst individual samples of epithelial cells derived from 24 normal
colorectal tissues; B) correlation amongst individual samples of epithelial cells derived from 13 colorectal tubular adenomas; C) correlation
amongst individual samples of epithelial cells derived from 24 colorectal Dukes’ C carcinomas and D) correlation amongst triplicate LCM
experiments.
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Page 5 of 13Table 2 Differentially expressed miRNAs in epithelial and stromal cells of colorectal tissues
Name Geomean Fold change Unpaired t-test Cell type
Epithelial Stromal Epithelial/stromal p-value
hsa-miR-143 64 512 0.1 1.30E-06 Stromal
hsa-miR-145 512 4096 0.1 5.60E-06 Stromal
hsa-miR-133a 2 16 0.1 2.40E-07 Stromal
hsa-miR-139-5p 2 8 0.3 2.20E-05 Stromal
hsa-miR-125b 256 1024 0.3 2.60E-07 Stromal
hsa-miR-149 8 32 0.3 8.30E-09 Stromal
hsa-let-7f-1* 1 8 0.1 6.80E-06 Stromal
hsa-miR-143* 1 8 0.1 1.80E-06 Stromal
hsa-miR-30a 32 128 0.3 5.30E-07 Stromal
hsa-miR-214 64 256 0.3 2.80E-06 Stromal
hsa-miR-199a-5p 128 512 0.3 6.20E-07 Stromal
hsa-miR-195 128 512 0.3 3.10E-06 Stromal
hsa-miR-365 128 512 0.3 3.60E-07 Stromal
hsa-miR-136 2 8 0.3 1.10E-05 Stromal
hsa-miR-129-3p 2 8 0.3 6.60E-05 Stromal
hsa-miR-30a* 1 4 0.3 4.00E-05 Stromal
hsa-miR-497 64 256 0.3 2.30E-05 Stromal
hsa-miR-140-5p 32 128 0.3 3.70E-07 Stromal
hsa-miR-877* 8 16 0.5 2.10E-05 Stromal
hsa-miR-199b-3p 512 1024 0.5 7.70E-07 Stromal
hsa-miR-22 512 1024 0.5 9.40E-06 Stromal
hsa-miR-490-3p 1 2 0.5 8.90E-05 Stromal
hsa-miR-23b 1024 2048 0.5 4.10E-06 Stromal
hsa-miR-140-3p 64 128 0.5 4.50E-05 Stromal
hsa-miR-141* 2 1 2 6.90E-05 Epithelial
hsa-miR-7-1* 4 2 2 6.20E-05 Epithelial
hsa-miR-194* 4 1 4 2.90E-06 Epithelial
hsa-miR-760 8 2 4 7.20E-05 Epithelial
hsa-miR-513c 4 1 4 3.80E-05 Epithelial
hsa-miR-200a* 8 2 4 1.70E-06 Epithelial
hsa-miR-148a 512 128 4 1.30E-06 Epithelial
hsa-miR-501-5p 8 2 4 4.10E-07 Epithelial
hsa-miR-601 16 2 8 5.60E-05 Epithelial
hsa-miR-7 64 8 8 5.00E-06 Epithelial
hsa-miR-500 16 2 8 5.10E-07 Epithelial
hsa-miR-210 128 16 8 1.30E-05 Epithelial
hsa-miR-892b 16 2 8 4.10E-09 Epithelial
hsa-miR-200b* 32 2 16 1.50E-08 Epithelial
hsa-miR-196a 64 2 32 5.90E-07 Epithelial
hsa-miR-192 2048 128 16 1.60E-07 Epithelial
hsa-miR-192* 64 2 32 1.40E-10 Epithelial
hsa-miR-96 64 2 32 9.60E-06 Epithelial
hsa-miR-203 128 2 64 2.70E-08 Epithelial
hsa-miR-215 1024 32 32 1.20E-06 Epithelial
hsa-miR-375 128 4 32 1.00E-05 Epithelial
hsa-miR-194 2048 16 128 1.20E-06 Epithelial
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Page 6 of 13biomarkers in solid tumors. This is due to the facts that
the tiny amounts of miRNA present in the cells
(~0.001-0.1% of total RNA) and RNA recovered from
LCM is typically very poor in both quality and quantity
using conventional LCM procedures [25]. RNA degrada-
tion is primarily due to endogenous RNases that are
activated in an aqueous environment. Based on this
observation, we tested ethanol fixation and RNase
inhibitor treatment on tissue preparations to procure
high-quality yields of RNA. We used ethanol fixation to
minimize the tissue sections for exposure to water,
whereas RNase inhibitor treatment was used to inhibit
the reactivation of endogenous RNases during the stain-
ing process.
We found that ethanol fixation of tissue sections is the
preferred procedure for ensuring the highest quality and
Figure 4 Cell type-specific miRNA expression profiles. A) hierarchical clustering of 51 miRNA expression profiles in LCM selected epithelial
and stromal cells from 18 colorectal tissues (n = 6 normal, n = 6 adenomas and n = 6 carcinomas); B) hierarchical clustering of 26 miRNA
expression profiles in LCM selected epithelial cells from the colorectal tissues; C) hierarchical clustering of 21 miRNA expression profiles in LCM
selected stromal cells from the colorectal tissues and D) hierarchical clustering of 46 miRNA expression profiles in the mixed cell types (epithelial
and stromal cells) from the colorectal tissues. The mean signal from biological replicate samples was used for the clustering. Colored bars
indicate the range of normalized log2-based signals.
Table 2: Differentially expressed miRNAs in epithelial and stromal cells of colorectal tissues (Continued)
hsa-miR-429 512 4 128 3.80E-08 Epithelial
hsa-miR-200b 2048 32 64 1.60E-05 Epithelial
hsa-miR-141 1024 8 128 6.60E-07 Epithelial
hsa-miR-200a 1024 8 128 7.90E-07 Epithelial
hsa-miR-200c 1024 8 128 1.10E-05 Epithelial
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Page 7 of 13yield of RNA from LCM. To maximize the balance
between tissue morphology and RNA quality, the sec-
tions on the slides should be immediately fixed with
100% ethanol at -25°C in the cryostat for 10 minutes,
and then stored at -80°C for 2 hours. This ethanol fixa-
tion procedure produced a 1.8-fold improvement in
R N Aq u a l i t ya n da1 . 5 - f o l di n c r e a s ei nR N Aq u a n t i t y
compared to the sections without the fixation. In agree-
ment with previous reports discussing LCM protocols
[26], the sections should not be dried on the slide at
room temperature. All reagents for fixation, staining and
dehydration should be cooled to 4°C. The staining
should be carried out on ice.
The efficacy of RNase inhibitor treatment on tissue
sections during the staining process is uncertain. Kube
et al. reported that RNase inhibitors could significantly
improve RNA quality [27], however, we did not observe
considerable improvement on either RNA quality or
quantity in the sections treated with RNase inhibitor. In
agreement with our observation, a recent study revealed
no difference in the quantity and quality of RNA recov-
ered from microdissected colon cancer samples with
and without RNase inhibitor treatment [28].
It has been shown that RNA can be damaged by heat,
UV light, chemical components of histological staining
and enzymatic degradation. Therefore, LCM itself can
affect the quality of total RNA. On the other hand, the
procedure of tissue dissection will destroy the integrity
of cells especially in an aqueous environment, mean-
while, endogenous RNases will be released and have
much chances to connect with RNA. In our study,
applying LCM lowered 30% of the RIN values
demonstrates that LCM can introduce RNA damage
during its procedure. It is crucial to thoroughly air-dry
the slides before placing them into the LCM instrument
for preserving RNA degradation.
We could not directly compare RNA quantity in the
tissue sections with and without LCM. Using our
improved protocol for tissue preparation, the yield of
total RNA from ~2 × 10
5 LCM selected epithelial cells
was between 500 and 1500 ng. The time required to
select and capture such an amount of relevant cells is
usually 1-2 hours when isolating cells located in a com-
plex tissue. The order of RNA quality after LCM is car-
cinoma (7.2 ± 1.2) > adenoma (5.7 ± 1.1) > normal
tissue (5.2 ± 1.5). This could be due to the fact that
RNase activity in the carcinoma tissue is lower than that
in the normal tissue [29].
Recently, Ibberson et al. reported that RNA degrada-
tion compromised the reliability of miRNA expression
profiling and stated that total RNA degradation with RIN
values less than 7 should not be used for analysis of indi-
vidual miRNAs [30]. In our study, we used a mirVana
miRNA Isolation kit to prepare total RNA for the
miRNA analysis. The RNA isolation procedure combin-
ing the advantages of organic extraction and solid-phase
extraction can effectively recover small RNAs. The RNA
quality recovered from our LCM and isolation proce-
d u r e si s3 7 %w i t hR I N≥ 7, 39% with RIN ≥ 5 and 24%
with RIN < 5. To minimize experimental variations, we
chose to use Agilent miRNA microarray, since the plat-
form features the direct end-labeling and profiling of
mature miRNAs from total RNA without any size fractio-
nation or amplification. Obviously, the different RNA
Table 3 Comparison of miRNA expression profiles between mixed and epithelial cell types of colorectal tumors
Name Mixed cell types
a Epithelial cell type
c
p value
b fold change p value
d fold change
Adenoma vs. paired nontumorous tissue
hsa-miR-20a 0.82 0.9 0.021 1.5
hsa-miR-21 0.006 1.6 0.004 2.2
hsa-miR-106a 0.19 1.2 0.658 1.3
hsa-miR-181b 0.27 1.2 0.702 0.8
hsa-miR-203 0.14 1.7 0.001 3.2
Carcinoma vs. paired nontumorous tissue
hsa-miR-20a < 0.001 2.3 0.02 2.9
hsa-miR-21 < 0.001 2.8 0.003 2.3
hsa-miR-106a < 0.001 2.4 0.032 4.6
hsa-miR-181b < 0.001 1.4 0.044 2.1
hsa-miR-203 < 0.001 1.8 0.248 1.8
a the data obtained from the previous report by Schetter et al. [24].
b Wilcoxon matched pairs test.
c the data obtained from this study.
d Matched pairs test.
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Page 8 of 13isolation methods and microarray platforms used in the
studies can affect the RNA quality and thus the miRNA
profiles. The tissues shall be procured immediately after
surgery, cut into small pieces (~1 cm
2 × 0.5 cm),
embedded in OCT compound, fast-frozen in liquid nitro-
gen and stored at -80°C. Using such frozen tissue proces-
sing, the RNA quality of our frozen tissues is 79% with
RIN ≥ 7 and 21% with RIN ≥ 5. Methods upstream of
RNA isolation are crucial for preserving RNA integrity.
We determined the correlation of LCM selected epithe-
lial cells derived from the same tissue type and variability
of the triplicate LCM experiments using the microarray
platform. We show that the correlation of the individual
samples from the same tissue type is between 0.937 and
0.963, while the correlation amongst the triplicate LCM
experiments is 0.999. We further applied quantitative
RT-PCR to cross-verify the expression patterns of 7 dif-
ferent miRNAs using 8 LCM selected epithelial cells. The
correlation of the fold changes between Agilent miRNA
microarray and quantitative RT-PCR are excellent (R =
0 . 9 9 6 ) .T h eh i g h l yr e p r o d u c i b l ed a t ad e m o n s t r a t et h a t
RNA quality with RIN value ≥ 5 obtained from our LCM
and RNA isolation procedures is generally sufficient for
genome-wide miRNA analysis.
High-throughput microarrays have significantly
enhanced our knowledge of cancer biology [31-33]. The
accuracy of microarray data, however, is determined by
the specificity of the input RNA. We can imagine diffi-
culties arising during microarray analysis of tissue when
there are varying levels of tumor cells versus normal
and stromal cells. For example, a tissue comprised of
60% tumor, 30% normal and 10% stromal cells, would
have non-cancer cell types contributing to more than
40% of the overall signal. Since the amount of non-can-
cer tissue in colorectal tumors is highly variable (20-
80%), taking a “whole tissue” approach to microarrays
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Figure 5 Across-platform comparison. A) comparison of the fold changes in sample pair 54 determined by Agilent miRNA microarrays and by
quantitative RT-PCR (54AL: LCM-selected epithelial cells of normal colorectal tissue; 54BL: LCM-selected epithelial cells of Dukes’ B carcinomas); B)
comparison of the fold changes in sample pair 62 determined by Agilent miRNA microarrays and by quantitative RT-PCR (62AL: LCM-selected
epithelial cells of normal colorectal tissue; 62BL: LCM-selected epithelial cells of Dukes’ B carcinoma); C) comparison of the fold changes in
sample pair 63 determined by Agilent miRNA microarrays and by quantitative RT-PCR (63AL: LCM-selected epithelial cells of normal colorectal
tissue; 63BL: LCM-selected epithelial cells of Dukes’ C carcinoma) and D) comparison of the fold changes in the sample pair 65 determined by
Agilent miRNA microarrays and by quantitative RT-PCR (65AL: LCM-selected epithelial cells of normal colorectal tissue; 65BL: LCM-selected
epithelial cells of Dukes’ D carcinoma). R indicates the average correlation of 7 individual miRNAs.
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t h o s ea t t a i n a b l eu s i n gL C Ms e l e c t i o no fo n l ye p i t h e l i a l
cancer cells. In our study on 18 colorectal tissues, we
found that the miRNAs in the epithelial cells could dif-
ferentiate three categories of colorectal tissues (normal,
adenoma and carcinoma), however, the miRNAs in both
stromal and mixed cell types could not separate adeno-
mas from normal tissues. When we compared the
expression profiles of 5 miRNAs from the report of
Schetter et al. [24] with those collected in our study, we
found that the overall fold-changes obtained on the
whole tissues were considerably lower than those deter-
mined by using the pure epithelial cells, especially in the
case of adenomas. For carcinomas, we observed the sig-
nificant concordance of the regulation trends between
the two studies, although the total RNA source and
microarray platforms used for both experiments were
not identical. For adenomas, we found the considerable
differences of the fold changes between the whole color-
ectal tissues and LCM-selected epithelial cells. Such dif-
ferences observed in both studies are mainly due to the
varying levels of the tumor cells in the whole tumor tis-
sues. In some cases, the tumor cells may be less than
10%. It is clear that the expression levels of the whole
tumor tissue cannot only represent the signals from the
tumor cells, but also from the normal epithelial cells
and other cell types of interstitial tissue. This demon-
strates the potential power of discovering miRNA bio-
markers in a complex tissue using the combination of
LCM with genome-wide miRNA analysis.
Most cancers are epithelial in origin and arise through
a stepwise progression from normal cells, through dys-
plasic cells, into malignant cells [34]. Focusing research
on cell-specific molecular biomarkers can help in the
development of novel concepts for diagnosis and treat-
ment of epithelial cancers. In our study, we discovered
51 differentially expressed miRNAs in the pure epithelial
and stromal cells. The miRNAs that are specifically
expressed in the epithelial cells hold potential utility in
the further discovery of cell-specific miRNA biomarkers
for epithelial cancers. Other miRNAs that are highly
expressed in the stromal cells might have values in the
establishment of their roles on immune function and
relate to cancer progression and recurrence in solid
tumors [35]. Our small study presents a good example
using the microdissection for elucidation of miRNA bio-
markers in specific cell populations. Additional confir-
matory studies, however, are required to establish the
full significance of our findings.
Conclusions
Our results show good quality and quantity of RNA
recovered from LCM using our improved procedures on
tissue preparation. By comparing the miRNA expression
profiles of colorectal tissues in the mixed cell types with
the pure epithelial cells, we demonstrate the feasibility
and potential power of discovering miRNA biomarkers
in complex tissue using the combination of LCM with
genome-wide miRNA analysis. Additionally, we discov-
ered 51 differentially expressed miRNAs in epithelial
and stromal cells. Such cell type-specific miRNAs have
great potentials in the development of novel approaches
for diagnosis and treatment of epithelial cancers. We
expect that our optimized ethanol-fixation protocol will
serve as a basic tool for molecular analysis of frozen tis-
sues. The protocol is simple and shall be easy to imple-
ment in a standard biology laboratory.
Methods
Frozen tissue sections
Colorectal tissues were obtained from the tissue bank at
Shanghai Medical College in Fudan University. All
patients who participated in the study had given
informed consent. The collection of the tissue speci-
mens in accordance with the protocol was approved by
the Institutional Review Board of Shanghai Medical Col-
lege. The tissues were procured immediately after sur-
gery, cut into the size of ~1 cm
2 × 0.5 cm pieces,
embedded in optimum cutting temperature (OCT) com-
pound, fast-frozen in liquid nitrogen and stored at
-80°C. Serial cryostat sections (10 μm) were cut at -25°C
by using SLEE Cryostat MNT Instrument (SLEE Medi-
cal GMBH, Mainz, Germany) and placed onto mem-
brane slides (Arcturus Veritas, Mountain View, CA).
Tissue preparation and LCM
Six different experiments on tissue preparations were
performed to determine the effects of tissue manipula-
tions on RNA quality and quantity (Table 1). Each
experiment was performed in duplicate for each of three
colorectal tissues. In total, six replicates were performed
per experiment (two technical and three biological repli-
cates). Concentration of RNase Inhibitor used in the
hemotoxylin solution was according to the manufac-
turer’s specified instruction (Promega, Madison, WI).
For the improved procedures on tissue preparation,
the sections were immediately fixed with 100% ethanol
in the cryostat at -25°C for 10 minutes and the slides
were stored in 100% ethanol at -80°C for an additional
2 hours. The slides were then washed with DEPC trea-
ted water on ice for 30 seconds and stained with
MHS128 hematoxylin solution (Sigma-Aldrich, St.
Louis, MO) for 1 minute. Finally, the slides were dehy-
drated with 100% ethanol for 30 seconds and xylene for
5 minutes and subsequently air-dried.
The stained slides were placed into a Veritas Micro-
dissection Instrument (Arcturus Veritas, Mountain
View, CA). The cells of interest (~2 × 10
5) were selected
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Page 10 of 13and captured using ultraviolet laser cutting following the
manufacturer’s recommended protocol. The LCM cap
was immediately placed in a microcentrifuge tube con-
taining 400 μL Lysis/Binding Buffer (Ambion, Austin,
TX), which was vortex mixed and stored upside down
at -80°C until RNA isolation. The essential protocol and
reagents for LCM were from Arcturus (Mountain View,
CA). For each tissue, hematoxylin and eosin (H&E)-
stained frozen sections were prepared to guide the area
of interest for LCM. Examples of LCM isolated cells
from colorectal tissues are shown in Figure 6 with a
schematic depiction of the improved LCM protocol
shown in Additional file 6.
Using the improved protocol for tissue preparation,
LCM was performed on 11 tissue sections (n = 4 normal,
n = 3 adenomas and n = 4 carcinomas) to compare the
RNA quality with and without LCM (Table 1). Addition-
ally, LCM was performed on 101 colorectal tissues (43
normal, 14 adenomas and 44 carcinomas) to examine the
consistency of RNA quality recovered from LCM. Further-
more, LCM was performed on 18 colorectal tissues (n = 6
normal, n = 6 adenomas and n = 6 carcinomas) to isolate
epithelial and stromal cells for genome-wide miRNA ana-
lysis. Finally, triplicate LCM experiments (~1 × 10
5 per
LCM) were independently performed on one Dukes’ B
carcinoma to isolate epithelial cells for determining the
variability of the LCM protocol.
RNA isolation and quality control
Total RNA was extracted from the tissue sections by
using mirVana miRNA isolation kit according to the
instructions from the manufacturer (Applied Biosystems,
Foster City, CA). The concentration was quantified by
NanoDrop 1000 Spectrophotometer (NanoDrop Tech-
nologies, Waltham, MA). The quality control of RNA
was performed by a 2100 Bioanalyzer using the RNA
6000 Pico LabChip kit (Agilent Technologies, Santa
Clara, CA). The quality was measured by using RNA
integrity number (RIN). A RIN score was generated for
each sample on a scale of 1-10 as an indication of RNA
quality [36,37]. The quality is considered to be excellent
for RIN >/= 7-10, good for RIN >/= 5 and poor for RIN
< 5. Variation of RNA quality and associated RIN scores
are displayed in Additional file 7.
Genome-wide miRNA analysis
Human miRNA microarrays (Agilent Technologies,
Santa Clara, CA) were used to compare the expression
profiles of 18 colorectal tissues (n = 6 normal, n = 6
adenomas and n = 6 carcinomas) between LCM selected
epithelial cells versus stromal cells. Furthermore, the
microarray platform was used to determine the reprodu-
cibility of the LCM protocol using the pure epithelial
cells isolated from 61 colorectal tissues (n = 24 normal,
n = 13 tubular adenomas and n = 24 Dukes’ C
Figure 6 Laser capture microdissection of colorectal cells. A) normal; B) adenoma and C) carcinoma. 1) H&E-stained slide (× 20); 2)
hematoxylin stained slide before LCM (× 20); 3) hematoxylin stained slide after LCM (× 20) and 4) cap showing adherent cells (× 20).
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Page 11 of 13carcinomas). The microarray contains probes for 723
human miRNAs from the Sanger database v.10.1. Total
RNA (100 ng) derived from each of the colorectal sam-
ples were used as inputs for labeling via Cy3 incorpora-
tion. Microarray slides were scanned by XDR Scan
(PMT100, PMT5). The labeling and hybridization were
performed at Shanghai Biochip Company according to
the protocols in the Agilent miRNA microarray system.
Quantitative RT-PCR
Quantitative RT-PCR was performed using Taqman
MicroRNA assays (Applied Biosystems, Foster City, CA)
according to the manufacturer’si n s t r u c t i o n sw i t ht h e
Light Cycling 480 system (Roche Applied Science, India-
napolis). The assays were performed for 7 miRNAs (hsa-
miR-143, hsa-miR-145, hsa-miR-195, hsa-miR-375, hsa-
miR-497, hsa-miR-7 and hsa-miR-96) using 8 LCM-
selected epithelial cells derived from 4 pairs of colorectal
tumor tissues. The expression level of the small nuclear
R N AU 4 7w a su s e da st h en o r m a l i z a t i o nc o n t r o l .A l l
assays were carried out in triplicate.
Data analysis
Significance analysis of different tissue preparations
Paired t-test was performed on RNA quality and quan-
tity data derived from the different tissue preparations.
The standard deviation (SD) of the replicate experi-
ments was determined to assess the variability of the tis-
sue preparations.
Differential miRNA expression analysis
The microarray image information was converted into
spot intensity values using Scanner Control Software
Rev. 7.0 (Agilent Technologies, Santa Clara, CA). The
signal after background subtraction was exported
directly into the GeneSpring GX10 software (Agilent
Technologies, Santa Clara, CA) for quantile normaliza-
tion. The mean normalized signal from biological repli-
cates was used for comparative expression analysis.
Unpaired t-test with Benjamini-Hochberg correction (p
value </= 0.001) was used to identify differentially
expressed miRNAs between epithelial and stromal cells.
O n e - w a ya n a l y s i so fv a r i a n c e( A N O V A )w i t hapv a l u e
</= 0.05 was performed to determine differentially
expressed miRNAs amongst normal, adenoma and carci-
noma tissues. Hierarchical clustering was performed
with Pearson correlation using the differentially
expressed miRNAs. The fold changes of expression sig-
nals between normal and tumor samples were calculated
from the normalized values.
Correlation analysis
Pearson correlation was performed with all of 723
human miRNAs after the quantile normalization. The
correlation (R) between individual samples in the same
tissue type was determined using the normalized signals.
Additional file 1: Effect of RNase inhibitor on RNA quality and
quantity. A) RNA quality (RIN scores) of tissue sections in the presence
(n = 6) and absence (n = 6) of RNase inhibitors and B) RNA quantity (ng)
of the tissue sections in the presence (n = 6) and absence (n = 6) of
RNase inhibitor. S1, S5 and S6 indicates sample 1, 5 and 6 respectively.
Error bars represent the corresponding SD.
Additional file 2: Expression levels of 723 human miRNAs in LCM
selected epithelial and stromal cells from colorectal tissue. The table
lists the mean normalized signals, the corresponding SD and fold
changes of 723 human miRNAs in LCM selected epithelial and stromal
cells of colorectal normal (n = 6), adenoma (n = 6) and carcinoma tissues
(n = 6).
Additional file 3: Differentially expressed miRNAs in LCM selected
epithelial cells from colorectal tissue. The table lists the mean
normalized signals, fold changes and ANOVA p-values of 26 differentially
expressed miRNAs in LCM selected epithelial cells of colorectal normal
(n = 6), adenoma (n = 6) and carcinoma tissues (n = 6).
Additional file 4: Differentially expressed miRNAs in LCM selected
stromal cells from colorectal tissue. The table lists the mean
normalized signals, fold changes and ANOVA p-values of 21 differentially
expressed miRNAs in LCM selected stromal cells of colorectal normal
(n = 6), adenoma (n = 6) and carcinoma tissues (n = 6).
Additional file 5: Differentially expressed miRNAs in the mixed cell
types (epithelial and stromal cells) from colorectal tissue. The table
lists the mean normalized signals, fold changes and ANOVA p-values of
46 differentially expressed miRNAs in the mixed cell types (epithelial and
stromal cells) of colorectal normal (n = 6), adenoma (n = 6) and
carcinoma tissues (n = 6).
Additional file 6: Schematic depiction of the improved protocol on
tissue preparation for laser capture microdissection. The figure
shows the procedures of the optimized ethanol-fixation protocol on
tissue preparation for LCM.
Additional file 7: Variation of RNA quality and its associated RIN
score. A) gel electrophoresis patterns of total RNA samples with various
RNA quality and B) electropherograms of total RNA samples with
associated RIN scores.
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